Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3ENW4 | ISIN: US00430H2013 | Ticker-Symbol: 1A80
Frankfurt
21.11.24
08:03 Uhr
1,590 Euro
-0,040
-2,45 %
1-Jahres-Chart
ACCELERATE DIAGNOSTICS INC Chart 1 Jahr
5-Tage-Chart
ACCELERATE DIAGNOSTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,5501,60016:51
1,5601,61016:51

Aktuelle News zur ACCELERATE DIAGNOSTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07.11.Accelerate Diagnostics GAAP EPS of -$0.59 misses by $0.12, revenue of $2.98M misses by $0.02M2
ACCELERATE DIAGNOSTICS Aktie jetzt für 0€ handeln
07.11.Accelerate Diagnostics, Inc - 10-Q, Quarterly Report-
07.11.Accelerate Diagnostics, Inc.: Accelerate Diagnostics Reports Third Quarter 2024 Financial Results26TUCSON, Ariz., Nov. 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the third quarter ended September...
► Artikel lesen
07.11.Accelerate Diagnostics, Inc - 8-K, Current Report-
01.10.Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System3
30.09.Accelerate Diagnostics' Accelerate Arc System Receives FDA 510 (k) Clearance1
30.09.Accelerate Diagnostics, Inc - 8-K, Current Report3
30.09.Accelerate Diagnostics, Inc.: Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc System311An automated platform designed to fight against Sepsis and Antimicrobial Resistance (AMR) Enables rapid, automated microbial identification on the Bruker MALDI Biotyper® CA System directly from positive...
► Artikel lesen
26.08.Accelerate Diagnostics, Inc - 8-K, Current Report2
12.08.Earnings call: Accelerate Diagnostics Q2 2024 results and Wave program update4
09.08.Accelerate Diagnostics GAAP EPS of -$0.50 beats by $0.05, revenue of $3M in-line1
08.08.Accelerate Diagnostics, Inc - 10-Q, Quarterly Report2
08.08.Accelerate Diagnostics reports success in WAVE trial2
08.08.Accelerate Diagnostics, Inc.: Accelerate Diagnostics Reports Second Quarter 2024 Financial Results102TUCSON, Ariz., Aug. 8, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter ended June 30, 2024. "During the quarter we completed...
► Artikel lesen
08.08.Accelerate Diagnostics, Inc - 8-K, Current Report1
03.06.Accelerate Diagnostics, Inc - 8-K, Current Report1
08.05.Accelerate Diagnostics, Inc.: Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results171TUCSON, Ariz., May 8, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial preliminary results for the first quarter ended March 31, 2024. "During the quarter...
► Artikel lesen
28.03.Accelerate Diagnostics, Inc.: Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results221TUCSON, Ariz., March 28, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and year ended December 31, 2023. "In 2023, we...
► Artikel lesen
08.01.Accelerate Diagnostics, Inc.: Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results285TUCSON, Ariz., Jan. 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing services that improve patient outcomes...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1